Cronos Group (CRON) vs Glass House Brands Subordinate Voting Shares (GLAS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cronos Group (CRON) has outperformed Glass House Brands Subordinate Voting Shares (GLAS) over the past year, gaining 23.7% versus a loss of 36.7%. Over five years, GLAS leads with a +2.7% price change compared with -40.9% for CRON. Cronos Group is the larger company by market cap ($1.19 billion vs $483.5 million), about 2.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRON | GLAS |
|---|---|---|
| Share price | $3.24 | $5.13 |
| Market cap | $1.19B | $483.46M |
| 1-day change | -1.37% | -0.58% |
| YTD return | +23.19% | -42.03% |
| 1-year return | +23.66% | -36.67% |
| 5-year return | -40.88% | +2.70% |
| P/E ratio (TTM) | 17.05 | — |
| Forward P/E | — | 22.80 |
| EPS (TTM) | $0.19 | $-0.73 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.61 | $13.93 |
| 52-week low | $2.28 | $4.97 |
| Distance from 52-week high | -10.20% | -63.17% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | -24.07% | +211.89% |
| Average volume | 1.14M | 735.63K |
| Shares outstanding | 368.41M | 88.00M |
| Employees | 610 | 357 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cronos Group is about 2.5 times larger than Glass House Brands Subordinate Voting Shares by market value ($1.19B vs $483.46M).
- CRON has outperformed GLAS by 60.3 percentage points over the past year.
About Cronos Group
CRON stock →Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.
Healthcare · Drug Manufacturers - Specialty & Generic · 610 employees
About Glass House Brands Subordinate Voting Shares
GLAS stock →Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.
Healthcare · Drug Manufacturers - Specialty & Generic · 357 employees
CRON vs GLAS FAQ
Which is bigger, Cronos Group or Glass House Brands Subordinate Voting Shares?
Cronos Group (CRON) is larger, with a market capitalization of $1.19B compared with $483.46M for Glass House Brands Subordinate Voting Shares (GLAS).
Which stock has performed better over the past year, CRON or GLAS?
CRON returned +23.66% over the past 12 months, compared with -36.67% for GLAS (price return, excluding dividends). Past performance does not predict future results.
Are Cronos Group and Glass House Brands Subordinate Voting Shares in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.